Next-generation sequencing

NGS testing can provide useful information that assists physicians including:

• Confirming the diagnosis of bleeding and thrombosis disorders.
• Providing clarity and actionable results in situations where other testing methodologies provide inconclusive results for patients.
• Identifying mutations that could explain patients’ unusual hemostatic phenotype and laboratory results.
• Assays with single/small gene panels, focused panels, and comprehensive panels for bleeding/coagulation disorders, coagulation/angioedema, fibrinogen disorders, and thrombosis disorders.